Baijin Life Science Holdings Limited, an investment holding company, is engaged in the procurement, processing, design, production, and wholesale distribution of pearls and jewellery.
Business Segments
The company operates through two distinct segments: Sales of Pearls and Jewellery Products, and Strategic Investment and Financial Services.
Sales of Pearls and Jewellery Products
The Sales of Pearls and Jewellery Products segment involves the design and sale of various jewellery products and...
Baijin Life Science Holdings Limited, an investment holding company, is engaged in the procurement, processing, design, production, and wholesale distribution of pearls and jewellery.
Business Segments
The company operates through two distinct segments: Sales of Pearls and Jewellery Products, and Strategic Investment and Financial Services.
Sales of Pearls and Jewellery Products
The Sales of Pearls and Jewellery Products segment involves the design and sale of various jewellery products and pearls. The operations focus on providing a diverse range of high-quality jewellery to meet customer demands. The marketing and distribution strategies employed here are tailored to both wholesale and retail settings, utilizing both traditional and modern distribution channels.
Strategic Investment and Financial Services
The Strategic Investment and Financial Services segment engages in investments in financial assets related to real estate and holdings in various associates. This diversified portfolio allows the company to maximize returns through strategic asset allocation and investment management practices. The company remains engaged in market analysis to capitalize on emerging opportunities.
Business Strategy
The company’s business strategy is centered on diversification and sustainable growth. By operating in both the jewellery and investment sectors, the company aims to leverage opportunities in a fluctuating market landscape. The strategy involves constant innovation in design and quality improvement of jewellery products. The company collaborates with experienced designers to ensure high standards, while also adopting a data-driven approach for strategic investments.
Products and Services
The company specializes in a wide range of jewellery products, including high-quality natural and cultured pearls sourced ethically. It also offers customized jewellery designs that cater to individual clients and seasonal collections.
The services offered include financial analysis and advisory services focusing on real estate investments and financial asset management. The company provides investors access to strategic opportunities in various sectors.
Geographical Markets Served
The company serves a broad geographical market, primarily focusing on Asia, including China, where significant operational facilities are located.
Seasonality
The company experiences seasonality in its operations, especially in the jewellery sector, with demand typically spiking during festive seasons and holidays.
Customers
The company serves a diverse range of customers, including jewellery retailers and individual customers seeking customized offerings.
Sales and Marketing Channels
The company adopts a multi-channel distribution strategy, including wholesale distribution and direct sales via retail outlets and online platforms.
History
The company was incorporated in 2014. The company was formerly known as Man Sang Jewellery Holdings Limited and changed its name to Affluent Partners Holdings Limited in February 2017 and then to Baijin Life Science Holdings Limited in 2025.